Responsive COVID-19 Vaccines for Recovery Project under the Asia Pacific Vaccine Access Facility (ADB-55084-001)

  • South Asia
Geographic location where the impacts of the investment may be experienced.
  • Nepal
Geographic location where the impacts of the investment may be experienced.
Financial Institutions
  • Asian Development Bank (ADB)
International, regional and national development finance institutions. Many of these banks have a public interest mission, such as poverty reduction.
Project Status
Stage of the project cycle. Stages vary by development bank and can include: pending, approval, implementation, and closed or completed.
Bank Risk Rating
Environmental and social categorization assessed by the development bank as a measure of the planned project’s environmental and social impacts. A higher risk rating may require more due diligence to limit or avoid harm to people and the environment. For example, "A" or "B" are risk categories where "A" represents the highest amount of risk. Results will include projects that specifically recorded a rating, all other projects are marked ‘U’ for "Undisclosed."
Voting Date
Jul 26, 2021
Date when project documentation and funding is reviewed by the Board for consideration and approval. Some development banks will state a "board date" or "decision date." When funding approval is obtained, the legal documents are accepted and signed, the implementation phase begins.
  • Education and Health
The service or industry focus of the investment. A project can have several sectors.
Investment Type(s)
The categories of the bank investment: loan, grant, guarantee, technical assistance, advisory services, equity and fund.
Investment Amount (USD)
$ 165.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Loan Amount (USD)
$ 165.00 million
Value listed on project documents at time of disclosure. If necessary, this amount is converted to USD ($) on the date of disclosure. Please review updated project documents for more information.
Primary Source

Original disclosure @ ADB website

Updated in EWS Mar 14, 2022

Disclosed by Bank Jul 26, 2021

Contribute Information
Can you contribute information about this project?
Contact the EWS Team

Project Description
If provided by the financial institution, the Early Warning System Team writes a short summary describing the purported development objective of the project and project components. Review the complete project documentation for a detailed description.

According to the ADB project page, the objective of the project is to support the procurement and delivery of safe and effective vaccines against COVID-19 through APVAX's RRC in compliance with ADB's vaccine eligibility criteria to the country. It aims to finance the procurement of about 15.9 million doses of vaccines, which will be administered to about 6.8 million Nepalese by 2024, with data collected and disaggregated by sex and age.


Since the first case of COVID-19 was confirmed in Nepal on 27 January 2020, 591,494 cases have been confirmed and 7,990 people have died from the virus as of 7 June 2021. The pandemic resulted in high costs to the country's overall health, well-being, and economy. The disease's infection rate previously peaked in October 2020 with a monthly average test positivity rate of more than 24%. After a subsequent decline, Nepal has been facing a second wave since April 2021, with test positivity above 45%. The crisis is compounded by the country's severe lack of qualified health care workers; there are reports of one nurse caring for 20 critically ill patients. Recognizing the need for vaccination, the government acted swiftly to roll out inoculations starting 27 January 2021. More than 2 million (2,113,080) people received the first dose and 691,494 the second dose by 7 June 2021. Nepal aims to inoculate 71.62% of its population. However, it has not secured a pipeline for vaccines and faces significant financing gaps for vaccine procurement. The government requires timely financial support to procure safe and effective vaccines and limit the adverse impacts of the pandemic.


Procurement will be undertaken in a manner consistent with simplified and expedient procedures permitted under the ADB's Procurement Policy (2017, as amended from time to time) and Procurement Regulations for ADB Borrowers (2017, as amended from time to time). Since the project will be financed under APVAX, ADB member eligibility restrictions will be waived and universal procurement will apply. The procurement of vaccine may be done through (i) Accessing additional vaccines through COVAX; (ii) Engaging UNICEF or other UN agencies to support procurement of vaccines outside COVAX; (iii) Entering into direct bilateral deals with vaccine manufacturers; and (iv) Entering into Government to Government (G2G) contract for procuring vaccines. ADB will prior review all agreements. Value for money in procurement will be achieved by (i) Selecting vaccines that are best suited to domestic supply chain; and (ii) the recommended procurement strategy involves entering into service contract with UNICEF outside COVAX facilities as UNICEF is best positioned to manage vaccine purchasing complexities and the intricate logistics requirements for these temperature-sensitive items and UNICEF has been assisting for a long period in supporting the vaccine procurement for Nepal's National Child Immunization Program. ADB's Anticorruption Policy (1998, as amended to date) will apply to all contracts to be financed under the loan.

Stakeholder Communication, Participation, and Consultation
During Project Design ADB closely coordinated with key development partners involved in the health sector, especially with those supporting the vaccination campaign, on risk communication and community engagement (RCCE) activities to inform all Nepali, with special attention to the poor and vulnerable, on the risks of the COVID-19 pandemic and the benefits of and access to vaccination using a variety of communication tools and techniques, including consultation.
During Project Implementation Civil society organizations will raise awareness about the vaccine to all Nepali, with special attention to women, poor, and vulnerable groups, through RCCE activities implemented by UNICEF and partially funded by ADB TA.
Investment Description
Here you can find a list of individual development financial institutions that finance the project.

Concessional ordinary capital resources lending

Contact Information
This section aims to support the local communities and local CSO to get to know which stakeholders are involved in a project with their roles and responsibilities. If available, there may be a complaint office for the respective bank which operates independently to receive and determine violations in policy and practice. Independent Accountability Mechanisms receive and respond to complaints. Most Independent Accountability Mechanisms offer two functions for addressing complaints: dispute resolution and compliance review.
Responsible ADB Officer Van Dael, Rudi Louis Hendrikus
Responsible ADB Department South Asia Department
Responsible ADB Division Human and Social Development Division, SARD
Executing Agencies
Ministry of Finance
Agriculture Program
The Government of Nepal
Singha Durbar
Kathmandu, Nepal

Implementing Agency:

Ministry of Health and Population

Laxman Aryal
Telephone No: +977 1 44262543
Ramshah Path, Kathmandu


Dr. Roshan Pokhrel, Chief Specialist

Mobile: 977-9852024180



Asian Development Bank:


Sungsup Ra
Human and Social Development Division (SAHS) Telephone No: +63 2 632 5628

2.Mission Leaders

Rudi Van Dael
Principal Portfolio Management Specialist Nepal Resident Mission
Telephone: +977 1 4005120

Dinesh Arora
Senior Health Specialist, SAHS

page12image670888608 page12image670888896

Mission Leaders

Dr. Roshan Pokhrel


Chief Specialist


Mobile: 977-9852024180



page12image670908224 page12image670908512

Telephone: +63 2 8632 4449


You can submit an information request for project information at:

ADB has a two-stage appeals process for requesters who believe that ADB has denied their request for information in violation of its Access to Information Policy. You can learn more about filing an appeal at:


The Accountability Mechanism is an independent complaint mechanism and fact-finding body for people who believe they are likely to be, or have been, adversely affected by an Asian Development Bank-financed project. If you submit a complaint to the Accountability Mechanism, they may investigate to assess whether the Asian Development Bank is following its own policies and procedures for preventing harm to people or the environment. You can learn more about the Accountability Mechanism and how to file a complaint at:

How it works

How it works